CRESCENT CAPITAL PARTNERS

CRESCENT CAPITAL PARTNERS is a Series C+ and buyout fund in the US, Australia, New Zealand and Europe writing $38M+ checks into Fintech, Healthcare, industrial-technology, business-services, manufacturing, distribution, consumer-brands, technology and education.

Stages: Series C+, buyout
Sectors: Fintech, Healthcare, industrial-technology, business-services, manufacturing, distribution, consumer-brands, technology, education
Check size: $38M+
Invests in: US-wide, Australia, New Zealand, Europe
Round role: Leads rounds
Actively investing: Yes
Founded: 2000
Assets under management: $4.5B (PE) / $50B+ (Credit)

Thesis

Crescent Capital Partners is a prominent alternative asset manager with a dual focus on private equity and credit, operating across Australia, New Zealand, and the United States. Founded in 2000, the firm manages approximately $4.5 billion in AUM for its private equity arm and over $50 billion in AUM for its credit strategies. Their investment thesis centers on a 'growth buyout' strategy targeting mid-market companies with strong market positions and clear growth potential. While a generalist PE manager, Crescent has a significant focus on healthcare (over 45% of PE investments), alongside industrial technology, business services, manufacturing, distribution, financial services, consumer brands, technology, and education. Their private equity business operates in Australia and New Zealand, while their credit strategies have a significant presence in the United States and Europe. The typical minimum equity cheque for private equity deals is AUD 60 million (USD 38 million).

Common questions

Does CRESCENT CAPITAL PARTNERS invest at the Series C+ stage?

Yes. CRESCENT CAPITAL PARTNERS lists Series C+ and buyout among the stages it invests in.

What check size does CRESCENT CAPITAL PARTNERS write?

CRESCENT CAPITAL PARTNERS writes $38M+ checks.

Where does CRESCENT CAPITAL PARTNERS invest?

CRESCENT CAPITAL PARTNERS invests in the US, Australia, New Zealand and Europe.